STAT

3 hurdles to bringing medical devices to the U.S. market

In theory, it's easier to bring medical devices to the market than drugs. But getting a device approved in the U.S. is often difficult.
Medical devices have historically been seen as having faster paths to market than their pharmacological counterparts. The growing requirement for cost-effectiveness trials may be slowing them down.

When a colleague and I started our medical device company in 2009, we were in our second year at Harvard Medical School. Some classmates joked that they would still be in residency by the time we had moved on to our next big idea. We knew better — we expected it to be a long haul. Eight years into our journey, thousands of individuals have used our product in countries where it has been approved. But we have yet to gain approval in the U.S. — a long and

Citiți o mostră, înregistrați-vă pentru a citi în continuare.

Mai multe de la STAT

STAT1 min cititeMedical
Opinion: Editor’s Note: This Opinion Piece Is Now Outdated
There is little doubt the Grail cancer test will engender more testings. But what we really want to know is whether getting the test helps people live longer or live…
STAT1 min cititeMedical
STAT+: Pharmalittle: Pfizer Agrees To Supply Covid-19 Vaccine To WHO Covax Program; FDA Approves First Injectable HIV Medicine
Pfizer and BioNTech agreed to supply their Covid-19 vaccine to the COVAX vaccine access scheme co-led by the World Health Organization.
STAT1 min cititeBiology
STAT+: Pharmalittle: Pfizer-BioNTech Vaccine Seems To Work Against Covid-19 Mutation; Sarepta Gene Therapy Shows Mixed Results
United Kingdom regulators cleared the Moderna Covid-19 vaccine, adding a third shot for emergency use against the pandemic as infections surge there.